April 10, 2026 Beyond Generics: Lupin Limited’s Dapagliflozin Approval Highlights Strategic Depth in Chronic Care February 1, 2026 USFDA Grants Final ANDA Approval to Indoco Remedies for Epilepsy Drug December 23, 2025 USFDA Flags Compliance Issues at Sun Pharma & Aurobindo Pharma After Inspections September 6, 2025 New Hope for Bipolar & Schizophrenia Patients : Lupin gets FDA Approval on Risperidone LAI New Hope for Bipolar & Schizophrenia Patients : Lupin gets… Read more July 25, 2025 NATCO Pharma’s API Facility Cleared by U.S. FDA in Mekaguda Inspection NATCO Pharma’s API Facility Cleared by U.S.FDA in Mekaguda Inspection… Read more 5/5
